<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Bristol-Myers Cuts The Abilify Sales Force</title>
	<atom:link href="http://www.pharmalot.com/2009/10/bristol-myers-cuts-the-abilify-sales-force/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2009/10/bristol-myers-cuts-the-abilify-sales-force/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:10:31 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Anonymous</title>
		<link>http://www.pharmalot.com/2009/10/bristol-myers-cuts-the-abilify-sales-force/#comment-437872</link>
		<dc:creator>Anonymous</dc:creator>
		<pubDate>Fri, 16 Oct 2009 13:24:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=19123#comment-437872</guid>
		<description>Yesterday AstraZeneca offered buyout packages to its entire sales force.  The CNS division is merging with Hospital and Respiratory is merging with Medical Care.  Do not know how many total reps they want to get rid of.</description>
		<content:encoded><![CDATA[<p>Yesterday AstraZeneca offered buyout packages to its entire sales force.  The CNS division is merging with Hospital and Respiratory is merging with Medical Care.  Do not know how many total reps they want to get rid of.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.214 seconds -->

